Filter
2794
Filtered Results: 2794
Text search:
monitoring
of
adverse
effects
Featured
Recommendations
323
New Publications
766
Language
Document type
No document type
1572
Guidelines
479
Studies & Reports
410
Manuals
150
Strategic & Response Plan
95
Training Material
33
Fact sheets
32
Situation Updates
15
Resource Platforms
3
Infographics
3
Brochures
1
Videos
1
Countries / Regions
India
142
Global
112
Kenya
69
Western and Central Europe
62
South Africa
61
Ethiopia
61
Nepal
54
Nigeria
49
Africa
48
Uganda
46
Ghana
41
Tanzania
40
Latin America and the Carribbean
39
Sierra Leone
35
Zambia
35
Malawi
33
Myanmar / Burma
33
Bangladesh
30
Liberia
30
Philippines
25
Rwanda
23
Ukraine
21
Zimbabwe
20
South–East Asia Region
19
Syria
17
East and Southern Africa
17
Eastern Europe
17
Namibia
17
Cambodia
16
Indonesia
13
Guinea
12
West and Central Africa
12
Lesotho
11
USA
11
Middle East and North Africa
11
Botswana
11
South Sudan
11
Senegal
10
Mozambique
10
Asia
10
Germany
10
Eastern Europe and Central Asia
10
Eswatini/ Swaziland
10
Congo, Democratic Republic of
8
Western Pacific Region
8
Sudan
8
Brazil
7
Thailand
6
Moldova
6
Russia
6
Burkina Faso
5
Venezuela
5
Lebanon
5
Yemen
5
Pakistan
5
Laos
4
Afghanistan
4
Mali
4
Somalia
4
Tajikistan
3
Colombia
3
Timor Leste/ East Timor
3
Cameroon
3
Niger
3
Haiti
3
Jordan
3
Vietnam
3
Bhutan
3
Ecuador
3
Benin
2
Gambia
2
China
2
Singapore
2
Kyrgyzstan
2
United Kingdom
2
Argentina
2
Sri Lanka
2
Egypt
2
Georgia
2
Central African Republic
2
Angola
2
Iraq
2
Madagascar
2
North Macedonia
1
North Korea
1
Australia
1
Kazakhstan
1
Chile
1
Iran
1
Albania
1
Canada
1
Fiji
1
Burundi
1
Peru
1
Vanuatu
1
Mauritania
1
Lithuania
1
Ireland
1
Paraguay
1
North America
1
Turkmenistan
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Papua New Guinea
1
Djibouti
1
Romania
1
Greece
1
Palestine
1
Poland
1
Chad
1
Authors & Publishers
Publication Years
Category
Countries
950
Clinical Guidelines
329
Public Health
170
Women & Child Health
169
Key Resources
135
Capacity Building
44
Pharmacy & Technologies
31
Toolboxes
Mental Health
240
COVID-19
211
TB
194
HIV
193
Planetary Health
139
Pharmacy
92
AMR
84
Caregiver
75
Rapid Response
74
NCDs
69
NTDs
65
Conflict
65
Global Health Education
57
Ebola
51
Refugee
46
Disability
43
Specific Hazards
33
Natural Hazards
33
Cholera
14
Zika
14
Polio
13
Health Financing Toolbox
11
Typhoon
2
Social Ethics
1
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicin...
The third edition, released in 2018, has grown to include a total of 18 chapters, contributed by 20 experts and authors from many countries. The goal remains the same: to educate primary care providers on the best practices in TB diagnosis, treatment and follow-up. All articles are richly illustrate...
These Guidelines on prudent use of antimicrobials in human health are based on a technical report prepared by the European Centre for Disease Prevention and Control (ECDC) with input from EU Member States experts and stakeholders, which should be referred to for details of the methodology used in cr...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the...
Millennium Development Goal 8E aims for affordable access to essential medicines. Essential medicines, as defined by WHO, are those that “satisfy the health-care needs of the majority of the population” and that should therefore “be available at all times in adequate amounts”. However, there...
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
Despite some improvements, current levels of air pollution still pose a considerable risk to the environment and to human health in the WHO European Region. One issue of concern is that monitoring of particulate matter is very limited in the countries of eastern Europe, the Caucasus and central Asia...
New and updated information.
Adverse health effects of hot weather and heat-waves are largely preventable. Prevention requires a portfolio of actions at different levels:from health system preparedness, coordinated with meteorological early warning systems, to timely public ...
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effective consumer reporting system within their pharmac...
The combined effects from ambient (outdoor) air pollution and indoor (household, in particular) air pollution cause approximately 7 million premature deaths every year, largely as a result of increased mortality from stroke, IHD, COPD, lung cancer and acute respiratory infections (1). Air pollution ...
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
SCOPING QUESTION: In adults with established status epilepticus (i.e., seizures persisting after the first-line treatment with benzodiazepines [or benzodiazepines-resistant status epilepticus]), which anti-epileptic medications are associated with cessation of seizures and reduced adverse effects)?
...
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A...
